Skip to content
Search

Latest Stories

Pharmacy closures spell trouble for healthcare suppliers and patients

Pharmacy closures spell trouble for healthcare suppliers and patients

With more than 350 closures in the past year alone, patients are facing difficulties in collecting their prescriptions

The escalating number of pharmacy closures across the UK has set off alarm bells among healthcare professionals and industry stakeholders alike.


According to recent findings from the Company Chemists’ Association (CCA), the tally of operational community pharmacies within NHS England hit a dismal low of 11,414 during the financial year 2022/2023. This drop, fueled by a net loss of 388 pharmacies, marks the lowest figure since 2015/16.

The CCA report further reveals a distressing trend: the rate of net closures is accelerating, with an average of eight pharmacies shutting down every week. Compounding the issue, over a third of these closures—37.5 per cent—have occurred in England’s most economically disadvantaged areas.

These revelations underscore the urgent need for action within the pharmaceutical supply chain. As pharmacies vanish from the high street, suppliers and distributors are grappling with disrupted distribution networks and dwindling avenues for product placement.

The recent closure of Lloyds Pharmacy outlets, a fixture on many UK high streets, has sent shockwaves through the industry.

With more than 350 closures in the past year alone, including the shuttering of all 237 Lloyds branches housed within Sainsbury’s supermarkets, the move has left patients and suppliers alike in limbo.

CCA chief executive Malcolm Harrison expressed grave concern over the news, stating that it could potentially impact the accessibility of medicines.

He noted that the exit of such a major player should serve as a "wake-up call" to both the government and the NHS.

Highlighting that pharmacies presently dispense over one billion NHS medicines annually to patients, he remarked that the ongoing closure of pharmacies will further degrade access to medicines and other critical primary care services.

Meanwhile, patients have conveyed to The Telegraph that they have been facing difficulties in collecting their prescriptions because there was no pharmacist available to dispense them.

Additionally, the pharmacy-led health and beauty retailer, Boots, put out a list of pharmacies shutting down in the beginning of 2024 as it moves forward with its plan to close 300 stores.

As the healthcare landscape evolves, continued delivery of vital medical products and services to communities across the UK remains a cause of concern for both, pharmacies and patients alike.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less